The multicenter, single-arm, phase 2 trial was conducted by Bernadett Szabados, MD, of the Queen Mary University of London and University College London Hospitals National Health Center Foundation Trust, and colleagues. The results were published in European Urology. ...
Muscle Invasive Urothelial Carcinoma
Urothelial Carcinoma Knowledge Hubs
Curated clinical content based on urothelial cancer types, therapies, and technologies
The first PET scans using Illuccix, Telix’s PSMA-PET imaging agent, have been carried out in cooperation with BAMF Health.
Nanobubbles can target membrane proteins, including PSMA, to bind to receptors that are overexpressed in cancer cells.
Few biomarkers predict therapeutic response to radiation or adjunctive treatments in PCa patients treated with radiotherapy.